Translational Healthcare Technologies
THT embraces a culture that is “people and team first” across disciplines to clinically and commercially translate scientific innovations for human healthcare benefit.
Our culture of friendship and support is key to our values and interactions with all our collaborators and partners.
The team, based within the Centre for Inflammation Research at the University Edinburgh, has affiliated group members from other leading UK Universities and UoE/NHS departments.
We fuse scientific discovery with clinical translation and challenge current human discovery, diagnostic and therapeutic pathways.
In the middle of 2020, half a year after COVID-19 changed the world as we knew it and we collectively entered a global pandemic, the STOPCOVID project at the Translational Healthcare Technologies group began recruiting participants for a drug trial called Define. ...
In February 2020, project teams funded through Round 1 of HTAF’s Confidence in Concept Award attended an intensive strategy and networking event hosted by the California Life Sciences Institute (CLSI) at their Bay Area Offices. This brought together the HTAF project...